Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma

被引:33
作者
Okada, Reona [1 ]
Koshizuka, Keiichi [1 ,2 ]
Yamada, Yasutaka [1 ]
Moriya, Shogo [3 ]
Kikkawa, Naoko [1 ,2 ]
Kinoshita, Takashi [2 ]
Hanazawa, Toyoyuki [2 ]
Seki, Naohiko [1 ]
机构
[1] Chiba Univ, Dept Funct Genom, Grad Sch Med, Chiba 2608670, Japan
[2] Chiba Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Chiba 2608670, Japan
[3] Chiba Univ, Dept Biochem & Genet, Grad Sch Med, Chiba 2608670, Japan
关键词
head and neck squamous cell carcinoma; microRNA; miR-99a-3p; passenger strand; antitumor; STAMBP; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; AMSH; MIR-145-3P; MIGRATION; INVASION; DEUBIQUITINATION; PHOSPHORYLATION; IDENTIFICATION;
D O I
10.3390/cells8121535
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To identify novel oncogenic targets in head and neck squamous cell carcinoma (HNSCC), we have analyzed antitumor microRNAs (miRNAs) and their controlled molecular networks in HNSCC cells. Based on our miRNA signature in HNSCC, both strands of the miR-99a-duplex (miR-99a-5p: the guide strand, and miR-99a-3p: the passenger strand) are downregulated in cancer tissues. Moreover, low expression of miR-99a-5p and miR-99a-3p significantly predicts poor prognosis in HNSCC, and these miRNAs regulate cancer cell migration and invasion. We previously showed that passenger strands of miRNAs have antitumor functions. Here, we screened miR-99a-3p-controlled oncogenes involved in HNSCC pathogenesis. Thirty-two genes were identified as miR-99a-3p-regulated genes, and 10 genes (STAMBP, TIMP4, TMEM14C, CANX, SUV420H1, HSP90B1, PDIA3, MTHFD2, BCAT1, and SLC22A15) significantly predicted 5-year overall survival. Notably, among these genes, STAMBP, TIMP4, TMEM14C, CANX, and SUV420H1 were independent prognostic markers of HNSCC by multivariate analyses. We further investigated the oncogenic function of STAMBP in HNSCC cells using knockdown assays. Our data demonstrated that the aggressiveness of phenotypes in HNSCC cells was attenuated by siSTAMBP transfection. Moreover, aberrant STAMBP expression was detected in HNSCC clinical specimens by immunohistochemistry. This strategy may contribute to the clarification of the molecular pathogenesis of this disease.
引用
收藏
页数:18
相关论文
共 53 条
  • [1] Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo
    Agromayor, Monica
    Martin-Serrano, Juan
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (32) : 23083 - 23091
  • [2] Clinical utility of circulating non-coding RNAs - an update
    Anfossi, Simone
    Babayan, Anna
    Pantel, Klaus
    Calin, George A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (09) : 541 - 563
  • [3] Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC
    Arai, Takayuki
    Okato, Atsushi
    Yamada, Yasutaka
    Sugawara, Sho
    Kurozumi, Akira
    Kojima, Satoko
    Yamazaki, Kazuto
    Naya, Yukio
    Ichikawa, Tomohiko
    Seki, Naohiko
    [J]. CANCER MEDICINE, 2018, 7 (05): : 1988 - 2002
  • [4] Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Argiris, Athanassios
    Harrington, Kevin J.
    Tahara, Makoto
    Schulten, Jeltje
    Chomette, Pauline
    Castro, Ana Ferreira
    Licitra, Lisa
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [5] Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
    Bonner, James A.
    Harari, Paul M.
    Giralt, Jordi
    Cohen, Roger B.
    Jones, Christopher U.
    Sur, Ranjan K.
    Raben, David
    Baselga, Jose
    Spencer, Sharon A.
    Zhu, Junming
    Youssoufian, Hagop
    Rowinsky, Eric K.
    Ang, K. Kian
    [J]. LANCET ONCOLOGY, 2010, 11 (01) : 21 - 28
  • [6] Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers
    Boufraqech, Myriem
    Zhang, Lisa
    Nilubol, Naris
    Sadowski, Samira M.
    Kotian, Shweta
    Quezado, Martha
    Kebebew, Electron
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (17) : 4491 - 4504
  • [7] Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102
  • [8] Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study
    Chen, Yu-ting
    Yao, Jian-ni
    Qin, Yu-tao
    Hu, Kai
    Wu, Fang
    Fang, Ye-ying
    [J]. FEBS OPEN BIO, 2018, 8 (08): : 1280 - 1298
  • [9] Case-control study of human papillomavirus and oropharyngeal cancer
    D'Souza, Gypsyamber
    Kreimer, Aimee R.
    Viscidi, Raphael
    Pawlita, Michael
    Fakhry, Carole
    Koch, Wayne M.
    Westra, William H.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (19) : 1944 - 1956
  • [10] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1856 - 1867